Table 2.
Treatment effect on QOL based on EQ-5D-3 L and SF-6D in the LEVA trial
| |
Baseline |
3 months |
1 year |
|||
|---|---|---|---|---|---|---|
| QOL a | P-value | QOL change from baseline | P-value | QOL change from baseline | P-value | |
|
Based on EQ-5D-3 L |
|
|
|
|
|
|
| Intervention group |
0.889 |
|
+0.013 |
0.60 |
+0.022 |
0.37 |
| Control group |
0.880 |
|
-0.017 |
0.56 |
-0.031 |
0.15 |
| Difference intervention-control |
+0.019 |
0.48 |
+0.030 |
0.43 |
+0.053 |
0.10 |
|
Based on SF-6D |
|
|
|
|
|
|
| Intervention group |
0.706 |
|
+0.048 |
<0.01 |
+0.047 |
<0.01 |
| Control group |
0.702 |
|
+0.020 |
0.09 |
+0.003 |
0.83 |
| Difference intervention-control | +0.004 | 0.82 | +0.028 | 0.17 | +0.044 | 0.03 |
aQOL, Quality of Life.